← Back to Patent Explorer
US4168312A Expired / Lapsed US ⏱️ 0.0 years remaining

Quinolone derivatives

Assignee: Merck Patent GmbH
•
Filing: 1977-11-08
•
Granted: 1979-09-18
•
Expires: 1997-11-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New quinolone derivatives of the Formula I ##STR1## wherein R 1 and R 2 are each H, F, Cl, Br, CF 3 or CH 3 O or a physiologically acceptable acid addition salt thereof possess pharmacological properties including thrombocyte aggregation inhibiting action.

Inventors

  • 👤 Erich Schacht
  • 👤 Hans Dahm
  • 👤 Reinhard Lissner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 18:51
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/20; C07D215/22; A; A61; A61P; A61P7/00; A61P7/02

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 50 words
a pharmaceutical composition in table, capsule or dragee form which comprises, in admixture with a pharmaceutically acceptable adjuvant, an amount effective to inhibit thrombocyte aggregation of a compound of the formula ##STR5## wherein R 1 and R 2 are each H, F, Cl, Br, CF 3 or CH 3 O.
Claim 2
Dependent Claim 50 words
a pharmaceutical composition in table, capsule or dragee form which comprises, in admixture with a pharmaceutically acceptable adjuvant, an amount effective to inhibit thrombocyte aggregation of a compound of the formula ##STR5## wherein R 1 and R 2 are each H, F, Cl, Br, CF 3 or CH 3 O.
Claim 3
Dependent Claim 10 words
The composition of claim 1 wherein R 1 is H.
Claim 4
Dependent Claim 13 words
A composition of claim 1 wherein, R 1 is Cl in the 6-position.
Claim 5
Dependent Claim 12 words
The composition of claim 1 wherein R 2 is CH 3 O.
Claim 6
Dependent Claim 12 words
The composition of claim 4 wherein R 2 is in the 4-position.
Claim 7
Dependent Claim 11 words
The composition of claim 1 wherein the compound therein is 1-p-methoxyphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one.
Claim 8
Dependent Claim 17 words
A compound selected from the group consisting of 1-o-methoxyphenyl-4-acetoxy-1,2-dihydro-quinoline-2-one; 1-m-methoxyphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one; 1-p-methoxyphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one; 1-o-trifluoromethylphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one; 1-m-trifluoromethylphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one; 1-p-trifluoromethylphenyl-4-acetoxy-1,2-dihydro-quinolin--2-one; 1-m-trifluoromethylphenyl-4-acetoxy-6-chloro-1,2-dihydro-quinolin-2-one; and 1-p-methoxyphenyl-4-acetoxy-6-chloro-1,2-dihydro-quinolin-2-one.
Claim 9
Dependent Claim 17 words
A compound selected from the group consisting of 1-o-methoxyphenyl-4-acetoxy-1,2-dihydro-quinoline-2-one; 1-m-methoxyphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one; 1-p-methoxyphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one; 1-o-trifluoromethylphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one; 1-m-trifluoromethylphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one; 1-p-trifluoromethylphenyl-4-acetoxy-1,2-dihydro-quinolin--2-one; 1-m-trifluoromethylphenyl-4-acetoxy-6-chloro-1,2-dihydro-quinolin-2-one; and 1-p-methoxyphenyl-4-acetoxy-6-chloro-1,2-dihydro-quinolin-2-one.
Claim 10
Dependent Claim 6 words
1-p-methoxyphenyl-4-acetoxy-1,2-dihydro-quinolin-2-one, a compound of claim 7.
Claim 11
Independent Claim 45 words
A method of inhibiting thrombocyte aggregation in mammals which comprises administering systemically thereto an amount of a compound of the formula ##STR6## wherein R 1 and R 2 are each H, F, Cl, Br, CF 3 or CH 3 O, effective to inhibit thrombocyte aggregation.
Claim 12
Independent Claim 45 words
A method of inhibiting thrombocyte aggregation in mammals which comprises administering systemically thereto an amount of a compound of the formula ##STR6## wherein R 1 and R 2 are each H, F, Cl, Br, CF 3 or CH 3 O, effective to inhibit thrombocyte aggregation.

References Cited (Backward Citations)

US2962523A Cited
US3635985A Cited
US4065457A Cited
US4065456A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-09-17 1983-03-19 1983-09-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-09-17 1987-03-19 1987-09-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-09-17 1991-03-19 1991-09-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag